TY - JOUR
T1 - GLIDE Score
T2 - Scoring System for Prediction of Procedural Success in Tricuspid Valve Transcatheter Edge-to-Edge Repair
AU - Gerçek, Muhammed
AU - Narang, Akhil
AU - Körber, M. Isabel
AU - Friedrichs, Kai P.
AU - Puthumana, Jyothy J.
AU - Ivannikova, Maria
AU - Al-Kazaz, Mohamed
AU - Cremer, Paul
AU - Baldridge, Abigail S.
AU - Meng, Zhiying
AU - Luedike, Peter
AU - Thomas, James D.
AU - Rudolph, Tanja K.
AU - Geisler, Tobias
AU - Rassaf, Tienush
AU - Pfister, Roman
AU - Rudolph, Volker
AU - Davidson, Charles J.
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/7
Y1 - 2024/7
N2 - Background: Tricuspid valve transcatheter edge-to-edge repair (T-TEER) is the most widely used transcatheter therapy to treat patients with tricuspid regurgitation (TR). Objectives: The aim of this study was to develop a simple anatomical score to predict procedural outcomes of T-TEER. Methods: All patients (n = 168) who underwent T-TEER between January 2017 and November 2022 at 2 centers were included in the derivation cohort. Additionally, 126 patients from 2 separate institutions served as a validation cohort. T-TEER was performed using 2 commercially available technologies. Core laboratory assessment of procedural transesophageal echocardiograms was used to determine septolateral and anteroposterior coaptation gap, leaflet morphology, septal leaflet length and retraction, chordal structure density, tethering height, en face TR jet morphology and TR jet location, image quality, and the presence of intracardiac leads. A scoring system was derived using univariable and multivariable logistic regression. Endpoints assessed were immediate postprocedural TR reduction ≥2 grades and TR grade moderate or less. Results: The median age was 82 years (Q1-Q3: 78-84 years); 48% of patients were women; and patients presented with severe (55%), massive (36%), and torrential (8%) TR. Five variables (septolateral coaptation gap, chordal structure density, en face TR jet morphology, TR jet location, and image quality) were identified as best predicting procedural outcome and were incorporated in the GLIDE (Gap, Location, Image quality, density, en-face TR morphology) score (range 0-5). TR reduction ≥2 grades and TR grade moderate or less were observed in >90% of patients with GLIDE scores of 0 and 1 and in only 5.6% and 16.7% of those with GLIDE scores ≥4. The GLIDE score was then externally validated in a separate cohort (area under the curve: 0.77; 95% CI: 0.69-0.86). TR reduction significantly correlated with functional improvement assessed by NYHA functional class and 6-minute walk distance at 3 months. Conclusions: The GLIDE score is a simple, 5-component score that is readily obtained during patient imaging and can predict successful T-TEER.
AB - Background: Tricuspid valve transcatheter edge-to-edge repair (T-TEER) is the most widely used transcatheter therapy to treat patients with tricuspid regurgitation (TR). Objectives: The aim of this study was to develop a simple anatomical score to predict procedural outcomes of T-TEER. Methods: All patients (n = 168) who underwent T-TEER between January 2017 and November 2022 at 2 centers were included in the derivation cohort. Additionally, 126 patients from 2 separate institutions served as a validation cohort. T-TEER was performed using 2 commercially available technologies. Core laboratory assessment of procedural transesophageal echocardiograms was used to determine septolateral and anteroposterior coaptation gap, leaflet morphology, septal leaflet length and retraction, chordal structure density, tethering height, en face TR jet morphology and TR jet location, image quality, and the presence of intracardiac leads. A scoring system was derived using univariable and multivariable logistic regression. Endpoints assessed were immediate postprocedural TR reduction ≥2 grades and TR grade moderate or less. Results: The median age was 82 years (Q1-Q3: 78-84 years); 48% of patients were women; and patients presented with severe (55%), massive (36%), and torrential (8%) TR. Five variables (septolateral coaptation gap, chordal structure density, en face TR jet morphology, TR jet location, and image quality) were identified as best predicting procedural outcome and were incorporated in the GLIDE (Gap, Location, Image quality, density, en-face TR morphology) score (range 0-5). TR reduction ≥2 grades and TR grade moderate or less were observed in >90% of patients with GLIDE scores of 0 and 1 and in only 5.6% and 16.7% of those with GLIDE scores ≥4. The GLIDE score was then externally validated in a separate cohort (area under the curve: 0.77; 95% CI: 0.69-0.86). TR reduction significantly correlated with functional improvement assessed by NYHA functional class and 6-minute walk distance at 3 months. Conclusions: The GLIDE score is a simple, 5-component score that is readily obtained during patient imaging and can predict successful T-TEER.
KW - transcatheter therapy
KW - tricuspid edge-to-edge valve repair
KW - tricuspid regurgitation
UR - http://www.scopus.com/inward/record.url?scp=85196355990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196355990&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2024.04.008
DO - 10.1016/j.jcmg.2024.04.008
M3 - Article
C2 - 38842961
AN - SCOPUS:85196355990
SN - 1936-878X
VL - 17
SP - 729
EP - 742
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 7
ER -